Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

36%

5 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
4(28.6%)
Phase 2
3(21.4%)
Phase 3
3(21.4%)
N/A
2(14.3%)
Phase 4
2(14.3%)
14Total
Phase 1(4)
Phase 2(3)
Phase 3(3)
N/A(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT05807529Phase 1Active Not Recruiting

A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis

Role: lead

NCT01710007Phase 3Completed

Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

Role: collaborator

NCT05926713Not ApplicableRecruiting

Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

Role: lead

NCT01265849Phase 3Completed

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity

Role: collaborator

NCT04349696Phase 4Completed

Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

Role: lead

NCT04229407Not ApplicableCompleted

Evaluate the Effect of Dietary Supplement on Muscle Mass and Physical Performance for Over 50 Years Old People

Role: lead

NCT02817113Phase 1Terminated

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Role: lead

NCT04229394Phase 1Completed

2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

Role: lead

NCT03771820Phase 2Unknown

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Role: collaborator

NCT02043288Phase 3Completed

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Role: lead

NCT04185129Phase 4Unknown

Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications

Role: collaborator

NCT01672008Phase 2Completed

NOX-100 for Preventing Hypotension During Hemodialysis

Role: collaborator

NCT01289574Phase 2Completed

Topical ASC-J9 Cream for Acne

Role: collaborator

NCT00910741Phase 1Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Role: collaborator

All 14 trials loaded